Delivery Order 36F79723D0136-36C26124N0465
Award Date
2/27/24
Potential Completion Date
5/28/24
Potential Value
$56K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Amylyx Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Cambridge, MA 02141, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amylyx Pharmaceuticals Inc. was awarded a firm fixed price delivery order for $204,836.65 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The delivery order is for the provision of RELYVRIO, Amylyx's pharmaceutical treatment for amyotrophic lateral sclerosis, to the place of performance in Cambridge, Massachusetts. The period of performance is from April 1, 2024 through June 30, 2024. Amylyx holds additional vehicles with the VA...
Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $74,879.68 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVIO. The contract has a period of performance from July 13, 2023 through September 13, 2023 and will be performed in Cambridge, Massachusetts. VHA VISN 21 oversees healthcare services for veterans in northern New England. This delivery order...
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business, for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The contract, valued at $44,459.84, was awarded on January 6, 2023, with a completion date of January 31, 2023. Amylyx holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a Federal Supply...
This federal contract award to Amylyx Pharmaceuticals Inc., doing business as Amylyx, is for the delivery of RELYVRIO Sodium, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The $42,334.56 firm-fixed-price delivery order was issued by the Veterans Integrated Service Network 21 (VISN 21), a division of the Department of Veterans Affairs (VA). The contract has no set-aside designation and is intended to supply RELYVRIO to VA medical facilities in the western United States....
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VA-VHA) awarded a $284,978.20 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract term is from June 2, 2023 through September 30, 2023 for the provision of RELYVRIO, a pharmaceutical product, to the VA-VHA. No subcontractors were identified.</p>
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Amylyx Pharmaceuticals Inc. for the provision of the drug RELYVRIO, which contains the active ingredients sodium phenylbutyrate and taurursodiol. The contract has a potential value of $93,599.60 and a completion date of April 20, 2024. Amylyx, a self-certified small disadvantaged business, has provided RELYVRIO to the VA through multiple federal contracts,...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
This federal contract award is a firm fixed-price delivery order issued by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract, valued at $485,835.00, is for the supply of DALFAMPRIDINE 100 MG, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract was awarded on January 17, 2017, with a final completion date of...
The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company that develops drugs to improve therapies for neurological conditions. The $485,835.00 contract is for the delivery of DALFAMPRIDINE 10MG SA, a pharmaceutical product, with a completion date of July 14, 2017. The contract was issued off of the VA's Pharmaceuticals and Drugs Federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,963.75 firm fixed price delivery order is for the supply of RADICAVA ORS STARTER KIT SUSP 35ML, a medication used in the treatment of amyotrophic lateral sclerosis (ALS). The contract has an ultimate completion date of October 19, 2023 and is not designated with a set-aside. Amerisourcebergen, the prime...